Clinical trial explores new ways to help chronic pain sufferers Medical Xpress "By comparing the brains of patients with osteoarthritis before and after the treatment we hope to achieve a better understanding of the mechanisms of pain relief. This will help us select patients who might benefit more from Duloxetine treatment … |
TUCSON, Ariz., Nov. 18, 2015 /PRNewswire/ — In a clinical trial conducted for HSRx Group, an Arizona-based biopharmaceutical company, the OTC acne treatment product HSRx 2121 significantly outperformed a market-leading product in reducing acne count …
acne treatment – Bing News
Xenon Pharmaceuticals Announces Initiation of XEN801 Phase 1 Clinical Trial Nasdaq 24, 2015 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced the initiation of a Phase 1 clinical trial of its lead proprietary program, XEN801, as a potential treatment for acne. |
